Skip to main navigation Skip to search Skip to main content

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma

  • Yung Kuan Tsou
  • , Kung Hao Liang*
  • , Wey Ran Lin
  • , Hsien Kun Chang
  • , Chen Kan Tseng
  • , Chau Ting Yeh
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

15 Scopus citations

Abstract

Esophageal squamous cell carcinoma is an aggressive cancer. We investigated genetic response predictors for patients with advanced esophageal squamous cell carcinoma receiving concurrent chemoradiotherapy. A cohort of 108 patients was recruited. Survival analysis showed that lower esophageal location of tumor, more advanced metastasis stage, and longer length of tumor were associated with poorer overall survival (adjusted P = 0.001, < 0.001, and 0.045, respectively), while the presence of complete/partial response to concurrent chemoradiotherapy was independently associated with better overall survival (adjusted P < 0.001). The GALNT14-rs9679162 "GG" genotype was associated with a lower rate of response (P = 0.014). Multivariate Cox-proportional hazards models also showed that the "GG" genotype was associated with a longer time to complete/partial response (adjusted P = 0.022), independent of leukocyte counts and gender. In conclusion, the presence of a complete/partial response to chemoradiotherapy was critical for advanced esophageal squamous cell carcinoma patients to achieve better overall survival. The GALNT14-rs9679162 "GG" genotype was associated with a longer time to complete/ partial response of concurrent chemoradiotherapy.

Original languageEnglish
Pages (from-to)29151-29160
Number of pages10
JournalOncotarget
Volume8
Issue number17
DOIs
StatePublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarker
  • Cisplatin
  • Gastrointestinal cancer
  • Germline polymorphism
  • Pharmacogenomics

Fingerprint

Dive into the research topics of 'GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this